Psoriasis is a chronic inflammatory skin disease that significantly impairs patients’ quality of life. Shared decision-making (SDM) enhances patient involvement in care but is underutilized in psoriasis management. The objective of this study is to develop a tailored SDM program for psoriasis patients in Taiwan and evaluate its feasibility, acceptability, and preliminary associations with perceived decision-making preparedness, satisfaction with clinician communication, self-reported decision-related anxiety, and treatment decision completion. A multidisciplinary team created an SDM program and paper-based patient decision aid (PDA) for adult patients with moderate-to-severe plaque psoriasis considering biologic treatments. In this retrospective single-group self-report survey, 72 patients completed a post-SDM questionnaire, including assessing perceived preparedness using the Preparation for Decision Making (PrepDM) scale and satisfaction with clinician communication using the CollaboRATE scale. Patients also retrospectively reported their pre-SDM decision status and self-reported decision-related anxiety in the same questionnaire and then reported their post-SDM status after the PDA-guided consultation. After the SDM consultation, the mean PrepDM score was 78.4 ± 21.0 out of 100, suggesting a high level of perceived decision-making preparedness, while the mean CollaboRATE score was 90.4 ± 12.3 out of 100, reflecting high satisfaction with clinician communication. The proportion of patients reporting that they had made a treatment decision by the end of consultation increased from 4.2% before SDM to 86.1% after SDM ( p < 0.001). Elevated self-reported decision-related anxiety decreased from 52.8% before SDM to 33.3% after SDM ( p = 0.029). In this retrospective single-group self-report survey, a culturally adapted SDM program for biologic treatment selection in psoriasis was feasible to implement and was associated with high perceived decision-making preparedness, high satisfaction with clinician communication, increased decision completion, and lower self-reported decision-related anxiety immediately after SDM. These findings should be cautiously interpreted as preliminary and hypothesis-generating. Further prospective controlled studies using validated decisional quality and anxiety measures are needed before causal conclusions or broader implementation recommendations can be made. Not applicable.
No takes yet. Share an insight, caveat, or question.
Yu‐Huei Huang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: